171 related articles for article (PubMed ID: 14965834)
1. Dynamics of intestinal flora after oral vaccination with inactivated whole-cell/recombinant B subunit O139 cholera vaccine.
Wu HX; Chen Q; Li JD; Huang XF
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):220-2, 225. PubMed ID: 14965834
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
3. Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers.
Torrell JM; Aumatell CM; Ramos SM; Mestre LG; Salas CM
Vaccine; 2009 Jun; 27(30):4074-7. PubMed ID: 19376179
[TBL] [Abstract][Full Text] [Related]
4. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
5. [Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine].
Chen Q; Yu S; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):330-3. PubMed ID: 9388905
[TBL] [Abstract][Full Text] [Related]
6. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
7. CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
Ahmed T; Arifuzzaman M; Lebens M; Qadri F; Lundgren A
Vaccine; 2009 Dec; 28(2):422-9. PubMed ID: 19837094
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
9. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of safety and effects on the oral whole cell/recombinant B subunit cholera vaccine in university students and workers].
Shi NM; Luo FJ; Li SM; Bai YH; Qu Y; Song X
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):192-5. PubMed ID: 20356556
[TBL] [Abstract][Full Text] [Related]
11. Oral vaccines for cholera control.
Chaturvedi S; Chaturvedi S
Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
[TBL] [Abstract][Full Text] [Related]
12. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
13. Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.
Roland KL; Cloninger C; Kochi SK; Thomas LJ; Tinge SA; Rouskey C; Killeen KP
Vaccine; 2007 Dec; 25(51):8574-84. PubMed ID: 18045752
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
15. Community-based assessment of safety and immunogenicity of the whole cell plus recombinant B subunit (WC/rBS) oral cholera vaccine in Peru.
Begue RE; Castellares G; Ruiz R; Hayashi KE; Sanchez JL; Gotuzzo E; Oberst RB; Taylor DN; Svennerholm AM
Vaccine; 1995 May; 13(7):691-4. PubMed ID: 7668039
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
[TBL] [Abstract][Full Text] [Related]
17. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
[TBL] [Abstract][Full Text] [Related]
18. Current status of cholera and rise of novel mucosal vaccine.
Yamamoto T
Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
[TBL] [Abstract][Full Text] [Related]
19. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
[TBL] [Abstract][Full Text] [Related]
20. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
